Clinical Trials Browser

Phase 2 × Lymphoma, T-Cell × Isotretinoin × Clear all

NCT00038376 2018-10-29

Phase II Study Of Roferon and Accutane For Patients With T-Cell Malignancies

Phase 2 Completed

LymphoidOther hematologic neoplasm

Mycosis Fungoides, Lymphoma, T-Cell, Hematologic Neoplasms